BRANDY ALIOTTA: Open Payments
NPI 1427112085 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 23 payments from 10 companies in 2025. Trend: 2023 $278 · 2024 $538 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $167 |
| MILLICENT US INC | 4 | $75 |
| Astellas Pharma US Inc | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Teleflex LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $25 |
| Exeltis, USA Inc. | 1 | $23 |
| Minerva Surgical, Inc | 1 | $22 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $22 |
| ConvaTec Inc. | 1 | $15 |
Products named: GEMTESA, Veozah, MYFEMBREE, FEMLYV, Mirena, QUIKCLOT, Wegovy, SLYND.
Industry payments across GA — which companies pay providers there.
